Qulipta 60 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5VHB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,757
Award facts
- Contract value 100% obligated
- $19,757.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,757.46 to AmerisourceBergen Drug Corp for the supply of Quilpta 60 mg tablets (30-count units) on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitive award, with no set-aside designation, was structured as a firm fixed-price delivery order for pharmaceutical delivery to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, executed this order under its parent company Cencora, Inc., which operates under the AmerisourceBergen trade name.
This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support contract for military healthcare programs. The IDC enables the company to supply a broad spectrum of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations, U.S. Coast Guard, and other federal government healthcare systems worldwide. The competitive nature of this award and the firm fixed-price structure reflect AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26F5VHB?
SPE2DR26F5VHB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F5VHB worth?
The government has obligated $19,757 on SPE2DR26F5VHB.
Is contract SPE2DR26F5VHB an order under another contract?
Yes. SPE2DR26F5VHB is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5VHB competed?
The extent of competition for SPE2DR26F5VHB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award